Download FREE Report Sample
Download Free samplePen needles are used in conjunction with injection pens to deliver injectable medications into the body.
Pen Needle for Diabete Patients Market contains market size and forecasts of Pen Needle for Diabete Patients in global, including the following market information:
Global Pen Needle for Diabete Patients Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pen Needle for Diabete Patients Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pen Needle for Diabete Patients companies in 2021 (%)
The global Pen Needle for Diabete Patients market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Standard Pen Needles Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pen Needle for Diabete Patients include BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed Holding, Owen Mumford, Beipu and Kangdelai, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pen Needle for Diabete Patients manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pen Needle for Diabete Patients Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pen Needle for Diabete Patients Market Segment Percentages, by Type, 2021 (%)
Standard Pen Needles
Safety Pen Needles
Global Pen Needle for Diabete Patients Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pen Needle for Diabete Patients Market Segment Percentages, by Application, 2021 (%)
Home Use
Medical Institutions
Global Pen Needle for Diabete Patients Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pen Needle for Diabete Patients Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pen Needle for Diabete Patients revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pen Needle for Diabete Patients revenues share in global market, 2021 (%)
Key companies Pen Needle for Diabete Patients sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pen Needle for Diabete Patients sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed Holding
Owen Mumford
Beipu
Kangdelai
Ulticare
Allison Medical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy